BlackRock Amends Health Catalyst Stake, Signals Continued Confidence
Ticker: HCAT · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 1636422
| Field | Detail |
|---|---|
| Company | Health Catalyst, Inc. (HCAT) |
| Form Type | SC 13G/A |
| Filed Date | Jan 24, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, healthcare-tech
TL;DR
**BlackRock still holds a big chunk of Health Catalyst, good sign for investors!**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 24, 2024, disclosing its ownership of Health Catalyst, Inc. common stock as of December 31, 2023. This amendment indicates BlackRock continues to hold a significant stake in Health Catalyst, Inc., a company specializing in computer programming and data processing services for healthcare. This matters to investors because BlackRock, a major institutional investor, maintaining its position signals continued confidence in Health Catalyst's future prospects, potentially influencing other investors' perceptions and the stock's stability.
Why It Matters
This filing shows that a major institutional investor, BlackRock, is maintaining its significant position in Health Catalyst, Inc., which can be seen as a vote of confidence in the company's long-term value.
Risk Assessment
Risk Level: low — This filing is an amendment showing a large institutional investor maintaining its position, which generally indicates stability rather than new risk.
Analyst Insight
Investors should note BlackRock's continued presence as a major shareholder, which could be a positive signal, but should also conduct their own due diligence on Health Catalyst's fundamentals.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Health Catalyst, Inc. (company) — the subject company whose common stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 24, 2024 (date) — the filing date of the SC 13G/A amendment
Forward-Looking Statements
- BlackRock will maintain a significant stake in Health Catalyst, Inc. throughout 2024. (BlackRock Inc.) — medium confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, filed under the Securities Exchange Act of 1934.
Which entity filed this SC 13G/A?
BlackRock Inc. filed this SC 13G/A, as indicated by the 'FILED BY' section and the cover page.
What is the subject company of this filing?
The subject company is Health Catalyst, Inc., as stated under 'Name of Issuer' on the cover page.
What was the 'Date of Event Which Requires Filing of this Statement'?
The date of the event requiring this filing was December 31, 2023, as specified on the cover page.
What is the CUSIP number for the class of securities reported?
The CUSIP number for the Common Stock of Health Catalyst, Inc. is 42225T107, as listed on the cover page.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 24, 2024 regarding Health Catalyst, Inc. (HCAT).